v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Fixed maturity securities available-for-sale, at fair value (amortized cost of $6,258,735 and $6,081,997 as of June 30, 2026, and December 31, 2025, respectively) $ 6,161,975 $ 6,050,542
Short-term investments, at fair value 49,123 0
Total investments 6,211,098 6,050,542
Cash and cash equivalents 448,446 582,493
Accrued investment income 62,381 56,073
Deferred acquisition costs 22,192 22,232
Premiums receivable 66,661 46,130
Other assets 112,364 116,007
Deferred tax asset 32,999 19,989
Total assets 6,956,141 6,893,466
Liabilities:    
Loss reserves 598,686 572,470
Unearned premiums 80,938 91,639
Other liabilities 135,750 129,695
Long-term borrowings 745,232 744,481
Total liabilities 1,560,606 1,538,285
Equity:    
Common stock ($0.01 par value; 600,000 shares authorized; 138,132 shares issued and outstanding as of June 30, 2026, and 142,209 shares issued and outstanding as of December 31, 2025) 1,381 1,422
Additional paid-in capital 1,521,281 1,706,481
Accumulated other comprehensive income (83,296) (30,143)
Retained earnings 3,956,169 3,677,421
Total equity 5,395,535 5,355,181
Total liabilities and equity $ 6,956,141 $ 6,893,466